Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapyMarkus Joerger, Jan H.M. Schellens, Alwin D. R. Huitema et al.|Cancer Chemotherapy and Pharmacology|2015Cited by 55